Azithromycin - Indications, Dose, Side effects, & Brands

Azithromycin belongs to the macrolide group of antibiotics. It interferes with bacterial protein synthesis by inhibiting the translation of mRNA.

It is used to treat the following conditions:

  • For the treatment of Chancroid (genital ulcer due to Haemophilus ducreyi).

  • For the treatment of bacterial exacerbation of Chronic obstructive pulmonary disease caused by:

    • Haemophilus influenzae

    • Moraxella catarrhalis

    • Streptococcus pneumoniae

  • For the prevention and treatment of Mycobacterium avium complex in patients with advanced HIV infection

  • For the treatment of acute otitis media caused by the following bacteria:

    • Haemophilus influenzae

    • M. catarrhalis

    • S. pneumoniae

  • For the treatment of community-acquired pneumonia caused by:

    • Chlamydophila pneumoniae

    • H. influenzae

    • Legionella pneumophila

    • M. catarrhalis

    • Mycoplasma pneumoniae

    • Streptococcus pneumoniae

  • Uncomplicated skin and soft tissue infections due to:

    • Staphylococcus aureus

    • Streptococcus pyogenes

    • Streptococcus agalactiae

  • As an alternative therapy for the treatment of tonsillitis or pharyngitis due to Streptococcus pyogenes.

  • For the treatment of Urethritis and cervicitis due to:

    • Chlamydia trachomatis

    • Neisseria gonorrhoeae

  • Off Label Uses of Azithromycin in Adults include:

    • Acne vulgaris

    • Babesiosis

    • For the prevention of pulmonary exacerbations in patients with Bronchiectasis (non-cystic fibrosis)

    • Bronchiolitis obliterans syndrome (in patients with lung transplant)

    • Campylobacter infection

    • Cat scratch disease

    • For perioperative prophylaxis during Cesarean delivery

    • Chlamydia trachomatis infection of the pharynx

    • For expedited partner therapy of Chlamydia trachomatis infection

    • Cholera

    • Prevention of pulmonary exacerbations in patients with Chronic obstructive pulmonary disease

    • Cystic fibrosis

    • Prophylaxis of endocarditis (prior to a dental or invasive respiratory tract procedure)

    • Disseminated gonococcal infection (including gonococcal arthritis, arthritis-dermatitis syndrome, meningitis, and endocarditis)

    • expedited partner therapy for Gonococcal infection

    • Uncomplicated Gonococcal infection of the rectum, pharynx, and conjunctiva

    • Granuloma inguinale

    • Lyme disease

    • Mycobacterium abscessus infection

    • Mycoplasma genitalium

    • Pertussis

    • For the prophylaxis of Sexually transmitted infections in individuals following a sexual assault

    • Shigella infection

    • Surgical prophylaxis in patients following uterine evacuation (after abortion or pregnancy loss)

    • Primary and Secondary Syphilis

    • Empiric treatment of Travelers' diarrhea

Azithromycin for the treatment of COVID-19 infection:

  • Azithromycin has recently been studied in patients with coronavirus infection along with the antimalarial drug hydroxychloroquine.
  • The author of the study suggested that the use of azithromycin in combination with hydroxychloroquine resulted in a significant reduction of positive cases after 6 days (25% vs 90%) [Ref].
  • Since both Azithromycin and hydroxychloroquine can result in QTc prolongation, this combination should be used with extreme caution.
  • Furthermore, more studies are needed before they are considered effective and safe.

Azithromycin Dose in Adults

Dose for Off-label use in the treatment of moderate to severe inflammatory Acne vulgaris as an adjunct to topical acne therapy:

  • Dosing regimens varied in different clinical trials.
    • Regimen 1:
      • 500 mg orally once a day for 4 consecutive days per month for 3 consecutive months or
    • Regimen 2:
      • 500 mg orally once a day for 3 days in the first week, followed by 500 mg once a week until week 10 or
    • Regimen 3:
      • 500 mg orally once a day for 3 consecutive days each week in month 1, followed by 500 mg once a day for 2 consecutive days each week in month 2, then 500 mg once a day for 1 day each week in month 3.

Dose for Off-label use in the treatment of Babesiosis:

  • Mild to moderate disease:

    • 500 mg orally on day 1, followed by 250 mg once a day in combination with atovaquone for 7 - 10 days in immunocompetent patients.

  • Severe disease:

    • 500 mg intravenous daily in combination with atovaquone for 7 - 10 days.

Dose for Off-label use in the treatment and prevention of pulmonary exacerbation of Bronchiectasis (non-cystic fibrosis):

  • 500 mg orally 3 times a week or 250 mg once a day.
  • All patients should be screened for non-tuberculous mycobacterial infection.

Dose for Off-label use in the treatment of Bronchiolitis obliterans syndrome in recipients of lung transplant:

  • 250 mg orally once a day for 5 days, followed by 250 mg 3 times a week for at least a 3 months.
  • Some experts continue it indefinitely regardless of the response to therapy.

Dose for Off-label use in the treatment of Cat scratch disease:

  • 500 mg orally as a single dose, then 250 mg once a day for 4 additional days.

Dose in the perioperative prophylaxis of Cesarean delivery:

  • 500 mg intravenous as a single dose one hour before a surgical incision in combination with standard preoperative antibiotics.

Dose in the treatment of Chronic obstructive pulmonary disease:

  • Treatment of Bacterial exacerbation:

    • 500 mg orally on day 1, followed by 250 mg once a day for a total of 5 days or
    • 500 mg orally once daily for three days.

  • Prevention of exacerbations as off-label use:

    • 250 - 500 mg orally 3 times a week or
    • 250 mg orally once a day

Dose as Off label use in the treatment of Cystic fibrosis as an anti-inflammatory drug:

  • 250 mg (individuals with a weight of less than 40 kg) or 500 mg (patients weighing more than 40 kgs) orally 3 times a week or
  • 250 mg once a day.

Dose as off Label use in the treatment of infectious Diarrhea:

  • Campylobacter infection:

    • 1 gm orally as a single dose (may administer 500 mg/day for 2 more days in symptomatic patients or
    • 500 mg orally once daily for three days
    • HIV infected patients should receive 500 mg once ay for 5 days.

  • As an alternative agent in Cholera:

    • 1 gm orally as a single dose

  • Shigella infection:

    • 500 mg orally once daily for three days
    • HIV patients and those with Shigella dysenteriae type 1 infection should be given the drug for 5 days.

  • Empiric treatment of Travelers' diarrhea:

    • 1 gm orally as a single dose (symptomatic patients may be advised the drug for 2 more days at a dose of 500 mg per day) or
    • 500 mg orally once daily for three days (it is considered the preferred regimen in febrile patients).

Off-label use for the prophylaxis of endocarditis prior to a dental or invasive respiratory procedure (as an alternative agent for penicillin-allergic patients):

  • 500 mg orally 30 - 60 minutes prior to the procedure.

Dose as Off-label use in the treatment of Lyme disease (erythema migrans or borrelial lymphocytoma) as an alternative agent:

    • 500 mg orally once a day for 7 - 10 days.

Dose in the treatment of non-tuberculosis Mycobacterial infection:

  • Mycobacterium avium complex (MAC) infection:

    • Disseminated disease in HIV-infected patients:

      • Treatment of MAC:

        • 500 - 600 mg orally once a day in combination therapy regimen

      • Primary prophylaxis (patients with CD4 count <50 cells/mm³ ):

        • 1,200 mg orally once a week (preferred) or
        • 600 mg orally twice a week
        • Prophylaxis may be discontinued when CD4 count is greater than 100 cells/mm³ for 3 months or more in response to antiretroviral therapy (ART).

      • Secondary prophylaxis:

        • 500 - 600 mg orally once a day in combination with other appropriate regimens
        • It may be discontinued when the patient has completed 12 months of therapy, with no features of MAC disease, and has a CD4 count of more than 100 cells/mm³ in response to ART for a sustained period (usually more than 6 months)

Off label use in the treatment of nodular or bronchiectatic pulmonary disease:

  • 500 - 600 mg orally 3 times a week until the patient is culture-negative on therapy for one year or more (in combination with other appropriate therapy)

Off label use in the treatment of severe nodular/ bronchiectatic or cavitary Pulmonary disease:

  • 250 - 500 mg orally once a day (in combination with other appropriate therapy)
  • The treatment should be continued until the patient is culture-negative on therapy for 1 year or more.

Dose as Off-label use in patients with cystic fibrosis: 

  • 250 - 500 mg orally once a day (in combination with other appropriate therapy) until the patient is culture negative for one year or more.
  • Patients with cystic fibrosis should not be advised intermittent (3 times a day) therapy.

Dose for Mycobacterium abscessus infection (off-label use):

  • Pulmonary, skin, soft tissue, or bone infection:

    • 250 - 500 mg orally once a day (in combination with other appropriate therapy)
    • For the treatment of pulmonary and bone infections, the treatment should be continued for 6 - 12 months, and for 4 months or more in patients with skin and soft tissue infections.

Off Label use in the treatment of Pertussis:

  • 500 mg orally on day 1, followed by 250 mg once a day for a total of 5 days.

Dose in the treatment of community-acquired Pneumonia:

  • Outpatient management:

    • 500 mg orally on day 1, followed by 250 mg once a day for 4 days or
    • 500 mg orally once daily for three days.

  • Inpatient management:

    • 500 mg orally or intravenously once a day for a minimum of 3 days.

Dose in the treatment of Sexually transmitted infections:

  • Empiric therapy for Cervicitis:

    • 1 gm orally as a single dose in combination with ceftriaxone.

  • Chancroid (caused by Haemophilus ducreyi ):

    • 1 gm orally as a single dose.

  • Chlamydia trachomatis infection of the urethra, cervix, or pharynx (as off-label use:

    • 1 gm orally as a single dose

  • Chlamydia trachomatis infection for the treatment of expedited partner (off-label use):

    • 1 gm orally as a single dose.

  • Disseminated Gonococcal Infection ( including arthritis, arthritis-dermatitis, meningitis, and endocarditis) as off label use:

    • 1 gm orally as a single dose in combination with ceftriaxone.

  • Gonococcal infection for expedited partner therapy (as off- label use):

    • 1 gm orally as a single dose in combination with cefixime.

  • Uncomplicated gonococcal infection (infection of the cervix, urethra, rectum, pharynx, or conjunctiva):

    • Dual-therapy regimen (as off-label use):

      • 1 gm orally as a single dose in combination with ceftriaxone

    • Patients with allergy to cephalosporins (as off-label use):

      • 2 gms as a single dose in combination with gemifloxacin or intramuscular gentamicin.

  • Granuloma inguinale (donovanosis) as off-label use:

    • 1 gm orally once a week or 500 mg once a day for 3 weeks or more and until the lesions have healed.
    • Gentamicin may be added to the therapy if the lesions are not healed within one week.

  • Mycoplasma genitalium (as off-label use):

    • 1 g orally as a single dose or
    • 500 mg orally on day 1, followed by 250 mg once a day for 4 days.

  • Prophylaxis against sexually transmitted infections following sexual assault (as off-label use):

    • 1 gm as a single dose in combination with ceftriaxone and metronidazole or tinidazole.

  • Primary and Secondary Syphilis in penicillin-allergic patients (off-label use):

    • 2 gms orally as a single dose.

  • For the empiric therapy of Urethritis:

    • 1 gm orally as a single dose in combination with ceftriaxone.

Dose in the treatment of group A streptococcal pharyngitis as an alternative agent for the severely penicillin-allergic patients:

  • 500 mg orally on day 1, followed by 250 mg once a day for 4 days or
  • 500 mg orally once daily for three days.

Off label use for the surgical prophylaxis of uterine evacuation in patients with abortion or a pregnancy loss:

  • 500 mg orally as a single dose one hour prior to the procedure.

Dose in the treatment of drug-resistant Typhoid fever:

  • 1 gm orally as a single dose, followed by 500 mg once a day for 7 - 10 days in combination with meropenem.

Azithromycin dose in the treatment of coronavirus infection:

  • 500 mg twice daily for five days along with hydroxychloroquine 400 mg twice daily on day one then 200 mg twice daily for four days.

Azithromycin Dose in Childrens

General dosing for susceptible infections:​​​​​​​

  • Mild to moderate infection:

    • 5 - 12 mg/kg/dose orally ( usually it is administered as 10 - 12 mg/kg/dose on day 1 followed by 5 - 6 mg/kg once a day.
    • The usual maximum dose for the total course is 1,500 - 2,000 mg.

  • Serious infection:

    • 10 mg/kg intravenous once a day to a maximum dose of 500 mg/dose.

Dose in the treatment of Babesiosis:

  • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose), then 5 mg/kg once a day on days 2 - 10 (maximum dose of 250 mg/dose) in combination with atovaquone.

Dose in the treatment of Bartonellosis (Cat scratch disease) with extensive lymphadenopathy in HIV-negative patients:​​​​​​​

  • Infants, Children, and Adolescents weighing 45 kgs or less:

    • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose, followed by 5 mg/kg once a day for 4 days to a maximum dose of 250 mg/dose.

  • Children and Adolescents weighing more than 45 kgs:

    • 500 mg orally as a single dose on day 1, then 250 mg once a day for 4 days.

Cutaneous bacillary angiomatosis (caused by B. henselae or B. quintana) in HIV-Positive patients:

  • 5 - 12 mg/kg orally once a day to a maximum dose of 600 mg/dose for 3 months.

Dose in the treatment of Chancroid:

  • Children weighing less than 45 kgs:

    • 20 mg/kg orally as a single dose (to a maximum dose of 1,000 mg/dose)

  • Children weighing more than 45 kgs:

    • 1,000 mg orally as a single dose

Dose in the treatment of Chlamydial infections:

  • Cervicitis and urethritis:

    • Children and Adolescents weighing more than 45 kgs:
      • 1,000 mg orally as a single dose

    • Conjunctivitis (infants):

      • 20 mg/kg orally or intravenous once a day for 3 days.

    • Community-acquired Pneumonia:

      • Mild infection or step-down therapy:

        • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose, followed by 5 mg/kg once a day for 4 days to a maximum dose of 250 mg/dose.

      • Severe infection:

        • 10 mg/ kg intravenous once a day for at least 2 days.
        • Switch to oral azithromycin as a single daily dose of 5 mg/kg (maximum 500 mg/dose) to complete the course.

    • For the treatment of patients with Cystic fibrosis to improve lung function and reduce the frequency of exacerbations:

    • Children older than 6 years and Adolescents:

      • 18 - 35.9 kg:

        • 250 mg orally three times a week (Monday, Wednesday, Friday)

      • More than 36 kgs:

        • 500 mg orally three times a week (Monday, Wednesday, Friday)

Dose in the treatment of infectious Diarrhea:

  • Campylobacter:

    • 10 mg/kg orally once a day for 3 days to a maximum dose of 500 mg/dose

  • Shigellosis:

    • AAP Recommendation:

      • 12 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose, followed by 6 mg/kg once a day for 4 days to a maximum dose of 250 mg/dose.

    • Alternate dosing:

      • 10 mg/kg orally once daily for three days
      • WHO Guidelines recommend up to 20 mg/kg/dose.

Use in the prophylaxis Endocarditis:

  • 15 mg/kg/dose orally 30 - 60 minutes prior to the procedure to a maximum dose of 500 mg/dose.

Use in the treatment of uncomplicated gonococcal cervicitis, urethritis, and anorectal disease:

  • Children less than 45 kgs:

    • 20 mg/kg orally as a single dose to a maximum dose of 1,000 mg/dose.

  • Children older than 8 years and weighing more than 45 kgs:

    • 1,000 mg orally as a single dose.

Use in the treatment of Group A streptococcal tonsillopharyngitis:

  • Manufacturer's labeling and AHA recommendations:

    • 2 mg/kg/dose orally once a day for 5 days to a maximum dose of 500 mg/dose.

  • Alternate dosing (IDSA recommendations):

    • 12 mg/kg orally to a maximum dose of 500 mg/dose on day 1 followed by 6 mg/kg/dose to a maximum dose of 250 mg/dose once a day for 4 days.

  • Three-day regimen:

    • 20 mg/kg/dose orally once a day for 3 days to a maximum dose of 1,000 mg/dose.

Use for the prophylaxis of Meningococcal disease in high-risk contacts:

  • 10 mg/kg orally as a single dose to a maximum dose of 500 mg/dose

Dose in the treatment of Mycobacterium avium complex (MAC) infection in HIV-positive patients:

  • Infants and Children:

    • Treatment of MAC infection:

      • 10 - 12 mg/kg orally once a day in combination with ethambutol (with or without rifabutin) to a maximum dose of 500 mg/dose for at least 12 months.

    • Primary prevention of first episode:

      • The preferred regimen is administered as 20 mg/kg once a week to a maximum dose of 1,200 mg/dose) or
      • alternatively 5 mg/kg once a day to a maximum dose of 250 mg/dose.​​​​​​​

    • Secondary prevention of recurring episodes:

      • 5 mg/kg once a day in combination with ethambutol (with or without rifabutin) to a maximum dose of 250 mg/dose.
  • Adolescents:

    • Treatment:

      • 500 - 600 mg orally once a day in combination with ethambutol

    • Primary prophylaxis:

      • 1,200 mg orally once a week or

      • alternatively, 600 mg two times a week

    • Secondary prophylaxis:

      • 500 - 600 mg once a day in combination with ethambutol

Use in the treatment of acute Otitis media (Should not be given routinely because of resistance):

  • Infants older than 6 months, Children, and Adolescents:

    • Single-dose regimen:

      • 30 mg/kg orally as a single dose to a maximum dose of 1,500 mg/dose.

    • Three-day regimen:

      • 10 mg/kg orally once a day for 3 days to a maximum dose of 500 mg/dose

    • Five-day regimen:

      • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose, followed by 5 mg/kg to a maximum dose of 250 mg/dose once a day for 4 days.

Dose in the treatment of peritonitis in patients on peritoneal dialysis and for the prophylaxis for patients receiving peritoneal dialysis prior to a dental procedure:

  • 15 mg/kg orally administered 30 - 60 minutes prior to a dental procedure to a maximum dose of 500 mg/dose.

Dose in the treatment of Pertussis:

  • Infants 1 - 5 months:

    • 10 mg/kg/dose once a day for 5 days

  • Infants older than 6 months, Children, and Adolescents:

    • 10 mg/kg once on day 1 to a maximum dose of 500 mg/dose, followed by 5 mg/kg once a day for 4 days to a maximum dose of 250 mg/dose.

Dose in the treatment of community-acquired Pneumonia (excluding mycoplasma pneumonia and chlamydial infections):

  • Immediate release:

    • Infants older than 3 months, Children, and Adolescents:

      • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose, followed by 5 mg/kg to a maximum dose of 250 mg/dose once a day for 4 days.

  • Extended-release oral suspension:

    • Infants older than 6 months, Children, and Adolescents:

      • 60 mg/kg orally as a single dose to a maximum dose of 2,000 mg/dose

    • Infants older than 3 months, Children, and Adolescents:

      • 10 mg/kg intravenous once a day for at least 2 days.
      • The intravenous therapy should be followed by oral treatment with a single daily dose of 5 mg/kg (maximum dose of 500 mg/dose) to complete a 5-day course of therapy.

Use in the treatment of community-acquired pneumonia due to mycoplasma pneumonia or chlamydial infection:

  • Infants older than 3 months, Children, and Adolescents:

    • Mild infection or step-down therapy:

      • 10 mg/kg orally once on day 1 to a maximum dose of 500 mg/dose followed by 5 mg/kg once a day for 4 days to a maximum dose of 250 mg/dose.

    • Severe infection:

      • 10 mg/kg intravenous once a day for at least 2 days to a maximum dose of 500 mg/dose.
      • Switch to the oral route with a single daily dose of 5 mg/kg (maximum of 250 mg/dose) to complete the course

Dose in the treatment of bacterial Rhinosinusitis:

  • Infants older than 6 months, Children, and Adolescents:
    • 10 mg/kg orally once a day for 3 days to a maximum dose of 500 mg/dose.

Dose in the prophylaxis of Sexual victimization:

  • Children less than 45 kgs:

  • Children older than 45 kg and Adolescents:

Dose in the treatment and prevention of Toxoplasmosis in HIV-positive patients:

  • 900 - 1,200 mg orally once a day in combination with pyrimethamine and leucovorin for 6 weeks (or longer if an extensive disease or incomplete response at 6 weeks).

Pregnancy Risk Factor B​​​​​​​

  • However, Azithromycin can cross the placental boundary, but adverse fetal outcomes were not observed in animal studies.
  • It is recommended to treat several infections during pregnancy, including:
    • Chlamydia
    • Gonococcal Infections
    • Mycobacterium avium complex (MAC)

Use of azithromycin while breastfeeding​​​​​​​

  • It is excreted from breast milk.
  • Maternal macrolides can cause nausea, vomiting, diarrhea, rash and somnolence in nursing infants.
  • Breastmilk can also contain antibiotics that may cause non-dose-related changes in the bowel flora. Monitor infants for signs and symptoms of gastrointestinal problems.
  • The data are inconsistent, but infantile hypertrophic Pyloric Steenisis has been linked to maternal use of macrolides during the first two weeks.
  • It is recommended to be used in breastfeeding women according to the manufacturer's instructions.
  • According to the CDC's Sexually Transmitted Diseases Treatment Guidelines it is recommended for treatment of granuloma Inguinale as well as as an alternative agent to treat lymphogranuloma venereum among lactating women.

Azithromycin Dose in Renal Disease:

  • Adjustment in the dose has not been provided by the manufacturer in patients with renal disease.
  • Patients with a CrCl of less than 10 ml/minute should be advised the drug with caution.

Azithromycin Dose in Liver Disease:

  • Adjustment in the dose has not been provided by the manufacturer in patients with liver disease.
  • However, since it is hepatically eliminated, it should be used with caution in patients with liver disease.
  • Patients who develop symptoms of hepatic impairment should immediately discontinue therapy.

Common Side Effects of Azithromycin Include:

  • Gastrointestinal:

    • Loose stools
    • Vomiting
    • Diarrhea

Less Common Side Effects of Azithromycin Include:

  • Cardiovascular:

    • Chest Pain
    • Palpitations

  • Central Nervous System:

    • Dizziness
    • Drowsiness
    • Fatigue
    • Headache
    • Vertigo

  • Dermatologic:

    • Skin Rash
    • Dermatitis
    • Pruritus
    • Skin Photosensitivity

  • Endocrine & Metabolic:

    • Increased Lactate Dehydrogenase
    • Increased Gammaglutamyl Transferase
    • Increased Serum Potassium
    • Decreased Serum Bicarbonate
    • Decreased Serum Glucose

  • Gastrointestinal:

    • Abdominal Pain
    • Anorexia
    • Dysgeusia
    • Dyspepsia
    • Flatulence
    • Gastritis
    • Melena
    • Mucositis
    • Oral Candidiasis

  • Genitourinary:

  • Hematologic & Oncologic:

    • Decrease In Absolute Neutrophil Count
    • Decreased Hematocrit
    • Decreased Hemoglobin
    • Increased Neutrophils
    • Thrombocythemia
    • Change In Neutrophil Count
    • Eosinophilia
    • Lymphocytopenia

  • Hepatic:

    • Increased Serum ALT
    • Increased Serum AST
    • Increased Serum Bilirubin
    • Cholestatic Jaundice

  • Local:

    • Pain At Injection Site
    • Local Inflammation

  • Neuromuscular & Skeletal:

    • Increased Creatine Phosphokinase

  • Renal:

    • Increased Serum Creatinine
    • Increased Blood Urea Nitrogen
    • Nephritis

  • Respiratory:

    • Bronchospasm

  • Miscellaneous:

    • Fever

Contraindication to Azithromycin Include:

  • Allergy reactions to azithromycin, Erythromycin, Other Macrolide Antibiotics, and any component of the formulation
  • Histories of hepatic dysfunction and cholestasis following prior azithromycin treatment.

Warnings and Precautions

  • Hypersensitivity reactions

    • Allergic reactions including anaphylaxis, angioedema, Stevens-Johnson syndrome, toxic epidermal necrolysis and drug reaction with eosinophilia and systemic symptoms [DRESS]) may occur that may be fatal at times.

  • Modified cardiac conduction

    • Patients with QTc prolongation, ventricular arrhythmias, or torsades-de-pointes should avoid Macrolides, especially erythromycin.
    • Patients with prolonged QT intervals, congenital long QT Syndrome, history of torsades, bradyarrhythmias and uncorrected hypomagnesemia/hypokalemia should avoid it.

  • Cardiac risk

    • Azithromycin is associated with a higher risk of developing a heart attack than amoxicillin or ciprofloxacin.

  • Superinfection

    • Extended use of azithromycin for more than two months has been linked to fungal and bacterial superinfections, including Clostridium difficile.

  • Gonorrhea, syphilis

    • Before initiating any treatment, it is important to perform appropriate culture and susceptibility testing.
    • This may be necessary because it can mask or delay symptoms such as syphilis or gonorrhea.

  • Hepatic impairment

    • Preexisting liver disease, hepatic impairment, hepatic necrosis and hepatic failure should be avoided.
    • Patients with symptoms of liver disease such as nausea, vomiting and colic should stop taking medication immediately.

  • Myasthenia gravis:

    • It can worsen myasthenia gravis symptoms.

  • Renal impairment

    • Patients with kidney disease should be cautious with this drug, particularly if their GFR is less than 10ml/minute.

Monitoring Parameters:

How to administer Azithromycin?

  • Intravenous administration:

    • It should not be injected as a bolus and should not be administered via the intramuscular route.
    • Infuse over one hour at a concentration of 2 mg/ml or over three hours (1 mg/ml infusion). Not for Intramuscular or Intravenous bolus administration.

  • Oral administration:

    • The immediate-release formulations may be taken without regard to meals.
    • The extended-release formulations should be taken via empty stomach (at least one hour before or two hours after a meal)

Mechanism of action of Azithromycin:

It is growing rapidly absorbed It is found in the gastrointestinal tract. It is widely distributed.

distributed In the tissues, including the skin, lungs and tonsils.

The CSF penetration is very poor. 7 to 51% of the drug are protein bound It is then metabolized by liver to inactive compounds.

BioavailabilityThe extended-release formulation has a 28% to 43% concentration, while the immediate-release formulations have a 34% to 52% concentration.

Half-life elimination Zithromycin is effective in children for 54.5 hours, adults for 68-72 hours with the immediate-release formulation and 59 hours with the extended-release formulation.

Time to get there peak serum concentration It takes 2 - 3 hours to prepare the immediate-release formulation, while the extended-release formulation takes 3 - 5 hours.

It is excreted via the bile (via bile) as an unchanged drug

Azithromycin international brands:

  • Ajustin
  • Aratro
  • Atizor
  • ATM-200
  • Aza-250
  • Aza-500
  • Azadose
  • Azas
  • Azath
  • Azatril
  • Azax
  • Azbact
  • Azce
  • Azee
  • Azeemycin
  • Azenil
  • Azent
  • Azi-500
  • Azibact
  • Azibiot
  • Azicine
  • Azilide-250
  • Azilide-500
  • Azimac
  • Azimacron
  • Azimax
  • Azimed
  • Azin
  • Azinobin
  • Aziphar
  • Aziraz
  • Azirocin
  • Azith
  • Azithral
  • Azithrin
  • Azithro
  • ACT Azithromycin
  • AG-Azithromycin
  • APO-Azithromycin
  • APO-Azithromycin Z
  • DOM-Azithromycin
  • GD-Azithromycin
  • GEN-Azithromycin
  • JAMP-Azithromycin
  • Mar-Azithromycin
  • MYLAN-Azithromycin
  • Novo-Azithromycin Pediatric
  • PHL-Azithromycin
  • PMS-Azithromycin
  • PRO-Azithromycin
  • RATIO-Azithromycin
  • RIntravenousA-Azithromycin
  • SANDOZ Azithromycin
  • TEVA-Azithromycin
  • Zithromax
  • Zmax SR
  • Azithrom
  • Azitops
  • Azitrex
  • Azitrix
  • Azitrocin
  • Azitromax
  • Azitrox
  • Aziwok
  • Azm
  • Azo-500
  • Azomycin
  • Azomyne
  • Azox
  • Azro
  • Azromax
  • Aztrin
  • Azyth
  • Azytro
  • Binozyt
  • Clindal AZ
  • Cronopen
  • Decantin
  • Enaz DS
  • Floctil
  • Glazi
  • Imexa
  • Inedol
  • Jazit
  • Koptin
  • Macromax
  • Macrozit
  • Maxmor
  • Mazit
  • Meithromax
  • Neazi
  • OD Mac
  • Odazyth
  • Onzet
  • Ormax
  • Shepherd
  • Thromaxin
  • Tromix
  • Ultreon
  • Unizithrin
  • Uzet
  • Vinzam
  • Weihong
  • Wiltrozin
  • Xithrone
  • Zaha-250
  • Zaret
  • Zarom
  • Zedbac
  • Zedd
  • Zemax
  • Zenith
  • Zeto
  • Zetron
  • Zicho
  • Zimac
  • Zimax
  • Zimericina
  • Zinfect
  • Zistic
  • Zithromac SR
  • Zithromax
  • Zithromax Intravenous
  • Zithrotel
  • Zithrox
  • Zitrim
  • Zitrocin
  • Zitrolin
  • Zitromax
  • Zmax
  • Zmax One Dose
  • Zocin
  • Zomax
  • Zymed
  • Zynomax
  • Zyomycin
  • Zythrocin

Azithromycin Brands in Pakistan

Azithromycin [Inj 500 Mg]
Acro S.J. & G. Fazul Ellahie (Pvt) Ltd.
Mezomed Mediate Pharmaceuticals (Pvt) Ltd
Nintramuscularoconil Vision 2000 Plus
Zeecin Wilshire Laboratories (Pvt) Ltd.
Zezot Bosch Pharmaceuticals (Pvt) Ltd.
Zithrax Biocare Pharmaceutical

Azithromycin [Inf 500 Mg]
Azintramuscularycin Mediceena Pharma (Pvt) Ltd.

Azithromycin [Susp 50 Mg/5ml]
Rasmic Rasco Pharma

Azithromycin [Susp 100 Mg/5ml]
Megazith Crest Pharmaceuticals

Azithromycin [Susp 125 Mg/5ml]
Reclocin Zinta Pharmaceuticals Industries

Azithromycin [Susp 200 Mg/5ml]
Acasia Nexpharm
Acro S.J. & G. Fazul Ellahie (Pvt) Ltd.
Alide Pharmix Laboratories (Printravenousate) Lintramuscularited.
Artiwin Wns Field Pharmaceuticals
Athofix The Schazoo Laboratories Ltd.
Axalina Alina Combine Pharmaceuticals (Pvt) Ltd.
Azicure Semos Pharmaceuticals (Pvt) Ltd.
Azidose Shaheen Pharmaceuticals
Azilite Webros Pharmaceuticals
Azintramuscularycin Mediceena Pharma (Pvt) Ltd.
Azirolide P.D.H. Pharmaceuticals (Pvt) Ltd.
Azirom Macquins International
Aziromycin Nawan Laboratories (Pvt) Ltd.
Azit Raazee Theraputics (Pvt) Ltd.
Azita Tg Pharma
Azitek Suspension Hygeia Pharmaceuticals
Azithro Goodman Laboratories
Azithrocin Bex Pharma (Pvt) Ltd.
Azithrosaf Saaaf Pharmaceuticals
Azintravenousid Multinational Buisness Link
Azo Ethical Laboratories (Pvt) Ltd.
Azobrain Winbrain Research Laboratories
Azocam Chas. A. Mendoza
Azocin Trison Research Laboratories (Pvt) Ltd
Azogil Glitz Pharma
Azolib Stalwart Pharmaceuticals (Pvt) Ltd
Azom Lotus Pharmaceuticals (Pvt) Ltd
Azomax Novartis Pharma (Pak) Ltd
Azomax Novartis Pharma (Pak) Ltd
Azomer Miracle Pharmaceuticals(Pvt) Ltd
Azores Saydon Pharmaceutical Industries (Pvt) Ltd.
Azorox Caylex Pharmaceuticals (Pvt) Ltd.
Azotine Nintramuscularrall Laboratories
Azoxin Flow Pharmaceuticals (Pvt) Ltd.
Azpar Zesion Pharmaceutical (Pvt) Ltd
Azrocin Obsons Pharmaceuticals
Azrowin Wns Field Pharmaceuticals
Bactizith W.Woodward Pakistan (Pvt) Ltd.
Biozit Leama Chemi Pharma (Pvt.) Ltd.
Chemzee Ideal Pharmaceutical Industries
Exonex Pharma Health Pakistan (Pvt) Ltd
Ezill Dr. Raza Pharma (Printravenousate) Lintramuscularited
Ezonex Mass Pharma (Printravenousate) Lintramuscularited
Fazi Farm Aid Group Pak Ltd.
Fenzy Noa Hemis Pharmaceuticals
Geozit Geofman Pharmaceuticals
Hyzitek Hygeia Pharmaceuticals
Kraze Medicaids Pakistan (Pvt) Ltd.
Legzith Legacy Pharmaceuticals
Maczin Mcolson Research Laboratories
Mezomed Mediate Pharmaceuticals (Pvt) Ltd
Mynex Nexus Pharma (Pvt) Ltd
Od-3 Adamjee Pharmaceuticals (Pvt) Ltd.
Orzit Seatle Pharma Pakistan (Pvt) Ltd.
Plazo Platinum Pharmaceuticals (Pvt.) Ltd.
Ramoff Valor Pharmaceuticals
Rasthro Rasco Pharma
Resque Standpharm Pakistan (Pvt) Ltd.
Romy Fozan Pharmaceuticals Industriers (Pvt) Ltd
Romycin Surge Laboratories (Pvt) Ltd.
Rothin Rakaposhi Pharmaceutical (Pvt) Ltd.
Servaz Kaizen Pharmaceuticals Pvt Ltd.
Spell Tagma Pharma (Pvt) Ltd.
Syzcin Sayyed Pharmaceuticals
Throb Bio Labs (Pvt) Ltd.
Welromycin Welwrd Pharmaceuticals
Xabest Everest Pharmaceuticals
Z-Mac Opal Laboratories (Pvt) Ltd.
Zatrocin Pearl Pharmaceuticals
Zeecin Wilshire Laboratories (Pvt) Ltd.
Zemark Unintramuscularark Pharmaceuticals
Zetro Getz Pharma Pakistan (Pvt) Ltd.
Zewin Orta Labs. (Pvt) Ltd.
Zezot Bosch Pharmaceuticals (Pvt) Ltd.
Zicure Medicaids Pakistan (Pvt) Ltd.
Zirocin Trigon Pharmaceuticals Pakistan (Pvt) Ltd.
Zitamax (Zithromax) Pfizer Laboratories Ltd.
Zithin Suspension Panacea Pharmaceuticals
Zithosintramuscular Sintramuscularz Pharmaceuticals
Zithrofame Lloyds Pharmaceuticals
Zithromed Medicraft Pharmaceuticals (Pvt) Ltd.
Zithrovel Well & Well Pharma (Pvt) Ltd
Zomax Helix Pharma (Printravenousate) Lintramuscularited
Zomax Helix Pharma (Printravenousate) Lintramuscularited
Zorix Lahore Chemical & Pharmaceutical Works (Pvt) Ltd
Zygrel Searle Pakistan (Pvt.) Ltd.
Zyson Suspension British Pharmaceuticals Ltd

Azithromycin [Susp 250 Mg/5ml]
Azicin Acme Laboratories Pakistan (Pvt) Ltd.
Azocure Orta Labs. (Pvt) Ltd.
Azorox Jawa Pharmaceuticals(Pvt) Ltd.

Azithromycin [Tabs 250 Mg]
Aptintramuscularac Aptcure Printravenousate Lintramuscularited
Atizor Macter International (Pvt) Ltd.
Austa-Z Bloom Pharmaceuticals (Pvt) Ltd.
Azelide Hygeia Pharmaceuticals
Azi-Once Tablet Crest Pharmaceuticals
Azia Medera Pharmaceuticals (Pvt) Ltd.
Azic Nabiqasintramuscular Industries (Pvt) Ltd.
Azintramuscularal Shazals Pharmaceuticals
Azintramuscularycin Mediceena Pharma (Pvt) Ltd.
Aziomak Makson Pharmaceuticals
Aziotic Everest Pharmaceuticals
Azir Innvotek Pharmaceuticals
Azirol Harmann Pharmaceutical Laboratories (Pvt) Ltd.
Azirom Macquins International
Azisia Ambrosia Pharmaceuticals
Azitab Cherwel Pharmaceuticals (Pvt) Ltd
Azitab Cherwel Pharmaceuticals (Pvt) Ltd
Azitek Tablet Hygeia Pharmaceuticals
Azithro Goodman Laboratories
Azithrosaf Saaaf Pharmaceuticals
Azintravenouser Florence Farmaceuticals (Pvt) Ltd
Aziwin Jinnah Pharmaceuticals
Azizox Alliance Pharmaceuticals (Pvt) Ltd.
Azobit Wns Field Pharmaceuticals
Azogil Glitz Pharma
Azoheintramuscular Pakheintramuscular Internanational Pharma
Azolintravenouse Olintravenouse Laboratories
Azopik Wise Pharmaceuticals (Pvt) Ltd
Azotek Saffron Pharmaceutical Company
Azure Fynk Pharmaceuticals
Biozith Bio Labs (Pvt) Ltd.
Blitz Biogen Pharma
Caramycin Caraway Pharmaceuticals
Conbac Convell Laboratories
Delide Dermagen Pharma Pakistan (Pvt) Lintramuscularited
Ery-Pack Lowitt Pharmaceuticals (Pvt) Ltd
Exthro Indus Pharma (Pvt) Ltd.
Ezmin Honig Pharmaceuticals Laboratories
Fenzy Noa Hemis Pharmaceuticals
Geozit Geofman Pharmaceuticals
Grazeth Gray`S Pharmaceuticals
Hyzitek Hygeia Pharmaceuticals
Hyzitek Hygeia Pharmaceuticals
Irzazitho Irza Pharma (Pvt) Ltd.
Kinra Tabros Pharma
Maczin Mcolson Research Laboratories
Maksin Trison Research Laboratories (Pvt) Ltd
Megatab Robins Pharmaceutical Industries
Mezith Qintar Pharmacuticals
Mynex Nexus Pharma (Pvt) Ltd
Myzi Pharmacare Laboratories (Pvt) Ltd.
Myzitro Miracle Pharmaceuticals(Pvt) Ltd
Ottocin Ottoman Pharma
Plazo Platinum Pharmaceuticals (Pvt.) Ltd.
Rasmic Rasco Pharma
Rasmic Rasco Pharma
Rasmic Rasco Pharma
Rasmic Forte Rasco Pharma
Rasthro Rasco Pharma
Reclocin Zinta Pharmaceuticals Industries
Servaz Kaizen Pharmaceuticals Pvt Ltd.
Silina Fassgen Pharmaceuticals
Spell Tagma Pharma (Pvt) Ltd.
Thron Linear Pharma
Winzith Pharmevo (Pvt) Ltd.
Zatrox Usawa Pharmaceuticals
Zee Danas Pharmaceuticals (Pvt) Ltd
Zeecin Wilshire Laboratories (Pvt) Ltd.
Zeerox Spl Pharmaceuticals (Pvt) Ltd
Zefed Fedro Pharmaceutical
Zepack Pearl Pharmaceuticals
Zesty Innvotek Pharmaceuticals
Zetro Getz Pharma Pakistan (Pvt) Ltd.
Zintramuscular Genome Pharmaceuticals (Pvt) Ltd
Zintramuscular Genome Pharmaceuticals (Pvt) Ltd
Zithin Tablet Wisdom Therapeutics
Zithrosafe Helicon Pharmaceutek Pakistan (Pvt) Ltd.
Zithrovel Well & Well Pharma (Pvt) Ltd
Zithrowan Swan Pharmaceuticals(Pvt) Ltd
Zitrex Genome Pharmaceuticals (Pvt) Ltd
Zitrex Genome Pharmaceuticals (Pvt) Ltd
Zitro Glitz Pharma
Zomysin Alkemy Pharmaceutical Laboratories (Printravenousate) Ltd.
Zycin Everest Pharmaceuticals

Azithromycin [Tabs 500 Mg]
Atizor Macter International (Pvt) Ltd.
Azintramuscularic Medera Pharmaceuticals (Pvt) Ltd.
Azithrosaf Saaaf Pharmaceuticals
Azintravenouser Florence Farmaceuticals (Pvt) Ltd
Azogil Glitz Pharma
Azomax Novartis Pharma (Pak) Ltd
Azomexin Paramount Pharmaceuticals
Azopik Wise Pharmaceuticals (Pvt) Ltd
Azotek Saffron Pharmaceutical Company
Azure Fynk Pharmaceuticals
Biozith Bio Labs (Pvt) Ltd.
Ery-Pack Lowitt Pharmaceuticals (Pvt) Ltd
Fenzy Noa Hemis Pharmaceuticals
Grazeth Gray`S Pharmaceuticals
Medi-Biotic Medicon Pharmaceuticals Industries (Pvt) Ltd
Mynex Nexus Pharma (Pvt) Ltd
Myzitro Miracle Pharmaceuticals(Pvt) Ltd
Ottocin Ottoman Pharma
Reclocin Zinta Pharmaceuticals Industries
Servaz Kaizen Pharmaceuticals Pvt Ltd.
Winzith Pharmevo (Pvt) Ltd.
Zee Danas Pharmaceuticals (Pvt) Ltd
Zeecin Wilshire Laboratories (Pvt) Ltd.
Zefed Fedro Pharmaceutical
Zetro Getz Pharma Pakistan (Pvt) Ltd.
Zezot Bosch Pharmaceuticals (Pvt) Ltd.
Zithrovel Well & Well Pharma (Pvt) Ltd
Zithrowan Swan Pharmaceuticals(Pvt) Ltd
Zitocin Genera Pharmaceuticals
Zomax Helix Pharma (Printravenousate) Lintramuscularited
Zycin Everest Pharmaceuticals

Azithromycin [Caps 250 Mg]
Acasia Nexpharm
Acro S.J. & G. Fazul Ellahie (Pvt) Ltd.
Akzith Akson Pharmaceuticals (Pvt) Ltd.
Alide Pharmix Laboratories (Printravenousate) Lintramuscularited.
Arcin Linear Pharma
Athofix The Schazoo Laboratories Ltd.
Azelide Hygeia Pharmaceuticals
Azera Medera Pharmaceuticals (Pvt) Ltd.
Azi-Once Capsule Rotex Medica Pakistan (Pvt) Ltd
Azibect Bryon Pharmaceuticals (Pvt) Ltd.
Azibect Bryon Pharmaceuticals (Pvt) Ltd.
Azicin Acme Laboratories Pakistan (Pvt) Ltd.
Azicure Semos Pharmaceuticals (Pvt) Ltd.
Azidose Shaheen Pharmaceuticals
Azigood Goodman Laboratories
Azilite Webros Pharmaceuticals
Azirolide P.D.H. Pharmaceuticals (Pvt) Ltd.
Aziromycin Nawan Laboratories (Pvt) Ltd.
Azit Raazee Theraputics (Pvt) Ltd.
Azithadvan Advanced Pharmaceuticals
Azithrocid Unintravenousersal Enterprises
Azithrocin Bex Pharma (Pvt) Ltd.
Azithromycin Unipharma (Pvt) Ltd.
Azithrosaf Saaaf Pharmaceuticals
Azithsun Hisun Pharmaceuticals
Azitral Nova Med Pharmaceuticals
Azix Prays Pharmaceuticals
Azizen Medizan Labs (Pvt) Ltd
Azo Ethical Laboratories (Pvt) Ltd.
Azocure Orta Labs. (Pvt) Ltd.
Azofas Fassgen Pharmaceuticals
Azogen Rogen Pharmaceuticals
Azolib Stalwart Pharmaceuticals (Pvt) Ltd
Azom Lotus Pharmaceuticals (Pvt) Ltd
Azomax Novartis Pharma (Pak) Ltd
Azomed Medera Pharmaceuticals (Pvt) Ltd.
Azomer Miracle Pharmaceuticals(Pvt) Ltd
Azomin Eg Pharmaceuticals
Azomite Ambrosia Pharmaceuticals
Azomite Ambrosia Pharmaceuticals
Azomycin Pulse Pharmaceuticals
Azores Saydon Pharmaceutical Industries (Pvt) Ltd.
Azorox Caylex Pharmaceuticals (Pvt) Ltd.
Azotag Biorex Pharmaceuticals
Azotine Nintramuscularrall Laboratories
Azowin Wise Pharmaceuticals (Pvt) Ltd
Azoxin Flow Pharmaceuticals (Pvt) Ltd.
Azpar Zesion Pharmaceutical (Pvt) Ltd
Azrocin Obsons Pharmaceuticals
Azrowin Wns Field Pharmaceuticals
Aztrix Medisure Laboratories Pakistan (Pvt.) Ltd.
Azza Genome Pharmaceuticals (Pvt) Ltd
Bactizith W.Woodward Pakistan (Pvt) Ltd.
Carown Crown Pharmaceuticals
Cinzit Shrooq Pharmaceuticals
Clozip Medisynth Pharmaceuticals
E-Thro Olintravenouse Pharmaceuticals
Enzoxen English Pharmaceuticals Industries
Ezill Dr. Raza Pharma (Printravenousate) Lintramuscularited
Ezintramuscularax Medipak Lintramuscularited
Ezonex Mass Pharma (Printravenousate) Lintramuscularited
Ezonex Mass Pharma (Printravenousate) Lintramuscularited
Fazi Farm Aid Group Pak Ltd.
Geozit Geofman Pharmaceuticals
Hazid Gray`S Pharmaceuticals
Hith Kanel Pharmaceuticals
Hyzith Axis Pharmaceuticals
Irzazitho Irza Pharma (Pvt) Ltd.
Kraze Medicaids Pakistan (Pvt) Ltd.
Macro-Z Z-Jans Pharmaceutical (Pvt) Ltd.
Macrobac Continental Chemical Company (Pvt) Ltd.
Macrocap Aries Pharmaceuticals (Pvt) Ltd
Macromax Mega Pharmaceuticals (Pvt) Ltd
Macromyd Global Pharmaceuticals
Macromyd Global Pharmaceuticals
Macropore Alson Pharmaceuticals
Macrozith Rock Pharmaceuticals
Maxibest Max Pharmaceuticals
Mylide Envoy Pharma
Od-3 Adamjee Pharmaceuticals (Pvt) Ltd.
Ram-Off Valor Pharmaceuticals
Rayaz Ray Pharma (Pvt) Ltd
Resque Standpharm Pakistan (Pvt) Ltd.
Rezoxin Reko Pharmacal (Pvt) Ltd.
Romy Fozan Pharmaceuticals Industriers (Pvt) Ltd
Romycin Surge Laboratories (Pvt) Ltd.
Rothin Rakaposhi Pharmaceutical (Pvt) Ltd.
Sintramuscularzith Sintramuscularz Pharmaceuticals
Syzcin Sayyed Pharmaceuticals
Throb Bio Labs (Pvt) Ltd.
Throb Bio Labs (Pvt) Ltd.
Wazocin Warafana Pharmaceuticals
Xabest Everest Pharmaceuticals
Xiaxi Evergreen Pharmaceuticals Pvt Lintramuscularited
Z-Mac Opal Laboratories (Pvt) Ltd.
Zatrocin Pearl Pharmaceuticals
Zemark Unintramuscularark Pharmaceuticals
Zetro Getz Pharma Pakistan (Pvt) Ltd.
Zewin Orta Labs. (Pvt) Ltd.
Zezot Bosch Pharmaceuticals (Pvt) Ltd.
Zicure Medicaids Pakistan (Pvt) Ltd.
Ziromac Zain Pharmaceutical
Ziromax Polyfine Chempharma (Pvt) Ltd.
Zitamax (Zithromax) Pfizer Laboratories Ltd.
Zith Silver Oak Corporation.
Zithro Unexo Labs (Pvt) Ltd.
Zithrofast Medifine Laboratories
Zithromed Medicraft Pharmaceuticals (Pvt) Ltd.
Zithrosan Sante (Pvt) Lintramuscularited
Zithrovel Well & Well Pharma (Pvt) Ltd
Ziton Shawan Pharmaceuticals
Zomax Helix Pharma (Printravenousate) Lintramuscularited
Zorix Lahore Chemical & Pharmaceutical Works (Pvt) Ltd
Zotter Highnoon Laboratories Ltd.
Zygrel Searle Pakistan (Pvt.) Ltd.

Azithromycin [Caps 500 Mg]
Acro S.J. & G. Fazul Ellahie (Pvt) Ltd.
Azicure Semos Pharmaceuticals (Pvt) Ltd.
Azilite Webros Pharmaceuticals
Azithadvan Advanced Pharmaceuticals
Azithromycin Unipharma (Pvt) Ltd.
Azocam Chas. A. Mendoza
Azogen Rogen Pharmaceuticals
Azomed Medera Pharmaceuticals (Pvt) Ltd.
Azomer Miracle Pharmaceuticals(Pvt) Ltd
Azotine Nintramuscularrall Laboratories
Azotine Nintramuscularrall Laboratories
Azoxin Flow Pharmaceuticals (Pvt) Ltd.
Azrowin Wns Field Pharmaceuticals
Bactizith W.Woodward Pakistan (Pvt) Ltd.
Cararox Caraway Pharmaceuticals
D-Kortes Zephyr Pharmatec (Pvt) Ltd.
E-Thro Olintravenouse Pharmaceuticals
Hazid Gray`S Pharmaceuticals
Macrozith Rock Pharmaceuticals
Megazith Crest Pharmaceuticals
Od-3 Adamjee Pharmaceuticals (Pvt) Ltd.
Ram-Off Valor Pharmaceuticals
Romy Fozan Pharmaceuticals Industriers (Pvt) Ltd
Syzcin Sayyed Pharmaceuticals
Zithromed Medicraft Pharmaceuticals (Pvt) Ltd.
Zonacin Akhai Pharmaceuticals.
Zygrel Searle Pakistan (Pvt.) Ltd.
Recent Posts
  • Brentuximab Vedotin 50 mg Price in Pakistan: Lowest and Cheapest
    07-09-2022
  • Diet Chart for Kidney Patients
    20-01-2022
  • Inosine pranobex (Isoprinosine) - Uses, Dose, Side effects, MOA
    13-12-2021
  • Xultophy 100/3.6 (Insulin Degludec and Liraglutide)
    13-12-2021

Comments

Khalid Jamal
[email protected]

Informative Sir... You are doing great

Related Posts
Aztreonam (Azactam) - for Gram-Negative Infections
13-12-2021
Bacitracin - an antibacterial agent for topical use
13-12-2021
Cefaclor (Ceclor) - a Second Generation Cephalosporin
13-12-2021
Cefpodoxime proxetil for respiratory and urogenital infections
13-12-2021